Previous 10 |
home / stock / cotqf / cotqf news
TORONTO and BOSTON, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT) (“Cotinga” or the “Company”) , a clinical-stage pharmaceutical company advancing a pipeline of targeted therapies for the treatment of cancer, announced today t...
TORONTO and BOSTON, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT) (“Cotinga” or the “Company”) , a clinical-stage pharmaceutical company advancing a pipeline of targeted therapies for the treatment of cancer, today announced t...
News, Short Squeeze, Breakout and More Instantly...
Cotinga Pharmaceuticals Inc Company Name:
COTQF Stock Symbol:
OTCMKTS Market:
TORONTO and BOSTON, July 18, 2019 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT) (“Cotinga” or the “Company”) , a clinical-stage pharmaceutical company advancing a pipeline of targeted therapies for the treatment of cancer, announced today t...
TORONTO and BOSTON, June 27, 2019 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT) (“Cotinga” or the “Company”) , a clinical-stage pharmaceutical company advancing a pipeline of targeted therapies for the treatment of cancer, announced today t...
TORONTO and BOSTON, June 05, 2019 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT) (“Cotinga” or the “Company”) , a clinical-stage pharmaceutical company advancing a pipeline of targeted therapies for the treatment of cancer, announced today t...